News & Updates
Filter by Specialty:
TCM shows potential for mild COVID-19 caused by Omicron
Longyizhengqi (LYZQ) granule, a traditional Chinese medicine (TCM), might be a promising drug for the treatment of mild COVID-19 caused by the Omicron variant, a prospective study from China suggests.
TCM shows potential for mild COVID-19 caused by Omicron
13 Jul 2023
Fremanezumab eases migraine and depressive symptoms
Treatment with fremanezumab – an anticalcitonin gene-related peptide (CGRP) – reduces depressive symptoms in patients with migraine and comorbid major depressive disorder (MDD) in the UNITE trial.
Fremanezumab eases migraine and depressive symptoms
13 Jul 2023
Urinary CKD273 predicts early renal damage in primary hypertension
A classifier developed based on 273 urinary peptides (CKD273) can predict new-onset proteinuria in patients with primary hypertension and be used to diagnose those with early renal injury, reports a study. This predictor contributes to the early prevention and treatment of hypertensive nephropathy.
Urinary CKD273 predicts early renal damage in primary hypertension
12 Jul 2023
Microencapsulated benzoyl peroxide cream alters skin microbiota, improves rosacea
Treatment with a microencapsulated benzoyl peroxide (E-BPO) 5% cream contributes to changes in the microbiome of the skin and results in improvements in moderate to severe rosacea, according to a study presented at the recent WCD 2023.
Microencapsulated benzoyl peroxide cream alters skin microbiota, improves rosacea
12 Jul 2023
Prediction model for stage I NSCLC refines follow-up strategy, personalizes therapy
A prediction model on disease recurrence for low-risk, resected stage I lung adenocarcinoma can classify postoperative patients with available clinical information and may even aid in personalizing a follow-up strategy and future adjuvant therapy, reports a study.